Vice President JD Vance will be in the Bay Area Friday evening for a fundraiser with a small group of Silicon Valley elites.

SGLT2 inhibitors reduced total cardiovascular risk by 18% in type 2 diabetes, with greatest benefit in patients at high risk for CVD recurrence.